4//SEC Filing
Huhn Stephen L. 4
Accession 0001437749-24-026903
CIK 0001855175other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 6:03 PM ET
Size
6.8 KB
Accession
0001437749-24-026903
Insider Transaction Report
Form 4
Huhn Stephen L.
CMO & Sr VP, Clinical Dev.
Transactions
- Exercise/Conversion
Class A Common Stock
2024-08-13$1.01/sh+12,800$12,928→ 12,800 total - Exercise/Conversion
Stock Option (right to buy)
2024-08-13−12,800→ 161,394 totalExercise: $1.01Exp: 2030-02-24→ Class A Common Stock (12,800 underlying)
Footnotes (2)
- [F1]This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of Class A Common Stock.
- [F2]Options granted under the Issuer's 2012 Equity Incentive Plan. The option is fully vested.
Documents
Issuer
Contineum Therapeutics, Inc.
CIK 0001855175
Entity typeother
Related Parties
1- filerCIK 0001863904
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 6:03 PM ET
- Size
- 6.8 KB